Has Dany Morel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,147 in general payments to Dany Morel, MD across 48 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dany Morel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dany Morel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dany Morel, MD

Hospitalist · Langhorne, PANPI 1497910202

Payments from drug & device makers

$1,147in general payments, 2019–2025

Across 48 payments — averaging $23.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$241
Boehringer Ingelheim$238
AstraZeneca$190
Pfizer$123
Merck$109
La Jolla Pharmaceutical Company$81
plus $166 from 5 others

What the payments were for

Food & beverage$1,147100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	11	$241
Boehringer Ingelheim	6	$238
AstraZeneca	7	$190
Pfizer	7	$123
Merck	5	$109
La Jolla Pharmaceutical Company	4	$81
Aimmune Therapeutics, Inc.	3	$64
Tetraphase Pharmaceuticals, Inc.	2	$45
Ceribell, Inc.	1	$25
Gilead	1	$16
E.r. Squibb & Sons, L.L.C.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

JARDIANCE$122

How this compares

$1,147 in reported general payments places this provider in the 90th percentile of 1,287 hospitalist providers in Pennsylvania.

See all hospitalist providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$161,097

Medicare patients

484

Services billed

1,483

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	13	$140
Cefdinir	12	$130
Pantoprazole Sodium	13	$106
Metoprolol Succinate	21	$98
ClopidogrelClopidogrel Bisulfate	14	$82
Furosemide	23	$65
Prednisone	15	$61
Cephalexin	14	$56
Doxycycline Hyclate	13	$47

Paid to pharmacies, not to this prescriber.

Other hospitalist in Langhorne

Umang PatelLanghorne$21K
Yaa OppongPhiladelphia$6.8M
Nader ZakiYork$706K
Chidiebube EgwimLebanon$224K
Khalid AhmedPhiladelphia$55K
Michael SchneiderPhiladelphia$37K
Irfan AhsanPhiladelphia$21K
Kevin VolppPhiladelphia$17K
Amanulla KhajiWynnewood$15K
Maria DrosouWynnewood$15K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →